150 related articles for article (PubMed ID: 34820689)
1. Combined arterial and delayed enhancement patterns of MRI assist in prognostic prediction for intrahepatic mass-forming cholangiocarcinoma (IMCC).
Jin KP; Sheng RF; Yang C; Zeng MS
Abdom Radiol (NY); 2022 Feb; 47(2):640-650. PubMed ID: 34820689
[TBL] [Abstract][Full Text] [Related]
2. Intrahepatic Mass-forming Cholangiocarcinoma: Arterial Enhancement Patterns at MRI and Prognosis.
Min JH; Kim YK; Choi SY; Kang TW; Lee SJ; Kim JM; Ahn S; Cho H
Radiology; 2019 Mar; 290(3):691-699. PubMed ID: 30620253
[TBL] [Abstract][Full Text] [Related]
3. Role of Central Hypo-enhancement in the Hepatic Arterial Phase of Dynamic Computed Tomography in Patients with Mass-Forming Intrahepatic Cholangiocarcinoma.
Teraoku H; Morine Y; Uyama N; Ikemoto T; Iwahashi S; Saito Y; Takasu C; Imura S; Harada M; Shimada M
World J Surg; 2020 Jul; 44(7):2350-2358. PubMed ID: 32152739
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging.
Kim R; Lee JM; Shin CI; Lee ES; Yoon JH; Joo I; Kim SH; Hwang I; Han JK; Choi BI
Eur Radiol; 2016 Jun; 26(6):1808-17. PubMed ID: 26373763
[TBL] [Abstract][Full Text] [Related]
5. Gadoxetic acid enhanced magnetic resonance imaging for prediction of the postoperative prognosis of intrahepatic mass-forming cholangiocarcinoma.
Kim S; An C; Han K; Kim MJ
Abdom Radiol (NY); 2019 Jan; 44(1):110-121. PubMed ID: 30078083
[TBL] [Abstract][Full Text] [Related]
6. Prediction for early recurrence of intrahepatic mass-forming cholangiocarcinoma: quantitative magnetic resonance imaging combined with prognostic immunohistochemical markers.
Zhao L; Ma X; Liang M; Li D; Ma P; Wang S; Wu Z; Zhao X
Cancer Imaging; 2019 Jul; 19(1):49. PubMed ID: 31307551
[TBL] [Abstract][Full Text] [Related]
7. Intrahepatic mass-forming cholangiocarcinoma: prognostic value of preoperative gadoxetic acid-enhanced MRI.
Koh J; Chung YE; Nahm JH; Kim HY; Kim KS; Park YN; Kim MJ; Choi JY
Eur Radiol; 2016 Feb; 26(2):407-16. PubMed ID: 26002136
[TBL] [Abstract][Full Text] [Related]
8. Intrahepatic mass-forming cholangiocarcinomas: enhancement patterns at multiphasic CT, with special emphasis on arterial enhancement pattern--correlation with clinicopathologic findings.
Kim SA; Lee JM; Lee KB; Kim SH; Yoon SH; Han JK; Choi BI
Radiology; 2011 Jul; 260(1):148-57. PubMed ID: 21474703
[TBL] [Abstract][Full Text] [Related]
9. Different MR features for differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma according to tumor size.
Ni T; Shang XS; Wang WT; Hu XX; Zeng MS; Rao SX
Br J Radiol; 2018 Jul; 91(1088):20180017. PubMed ID: 29791202
[TBL] [Abstract][Full Text] [Related]
10. Combined hepatocellular carcinoma-cholangiocarcinoma: MRI features correlated with tumor biomarkers and prognosis.
Zhou C; Wang Y; Ma L; Qian X; Yang C; Zeng M
Eur Radiol; 2022 Jan; 32(1):78-88. PubMed ID: 34279688
[TBL] [Abstract][Full Text] [Related]
11. DCE-MRI based radiomics nomogram for preoperatively differentiating combined hepatocellular-cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma.
Zhou Y; Zhou G; Zhang J; Xu C; Zhu F; Xu P
Eur Radiol; 2022 Jul; 32(7):5004-5015. PubMed ID: 35128572
[TBL] [Abstract][Full Text] [Related]
12. Delayed-phase dynamic CT enhancement as a prognostic factor for mass-forming intrahepatic cholangiocarcinoma.
Asayama Y; Yoshimitsu K; Irie H; Tajima T; Nishie A; Hirakawa M; Nakayama T; Kakihara D; Taketomi A; Aishima S; Honda H
Radiology; 2006 Jan; 238(1):150-5. PubMed ID: 16304089
[TBL] [Abstract][Full Text] [Related]
13. A proposal of imaging classification of intrahepatic mass-forming cholangiocarcinoma into ductal and parenchymal types: clinicopathologic significance.
Rhee H; Kim MJ; Park YN; An C
Eur Radiol; 2019 Jun; 29(6):3111-3121. PubMed ID: 30560357
[TBL] [Abstract][Full Text] [Related]
14. Enhancement patterns of intrahepatic mass-forming cholangiocarcinoma at multiphasic computed tomography and magnetic resonance imaging and correlation with clinicopathologic features.
Ciresa M; De Gaetano AM; Pompili M; Saviano A; Infante A; Montagna M; Guerra A; Giuga M; Vellone M; Ardito F; De Rose A; Giuliante F; Vecchio FM; Gasbarrini A; Bonomo L
Eur Rev Med Pharmacol Sci; 2015 Aug; 19(15):2786-97. PubMed ID: 26241531
[TBL] [Abstract][Full Text] [Related]
15. Mass-forming intrahepatic cholangiocarcinoma: Can diffusion-weighted imaging predict microvascular invasion?
Zhou Y; Wang X; Xu C; Zhou G; Liu X; Gao S; Xu P
J Magn Reson Imaging; 2019 Jul; 50(1):315-324. PubMed ID: 30444023
[TBL] [Abstract][Full Text] [Related]
16. Enhancement Patterns of Intrahepatic Cholangiocarcinoma on Contrast-Enhanced Ultrasound: Correlation with Clinicopathologic Findings and Prognosis.
Yuan M; Li R; Zhang Y; Yang L; Zhang X; Tang C; Guo D
Ultrasound Med Biol; 2019 Jan; 45(1):26-34. PubMed ID: 30292461
[TBL] [Abstract][Full Text] [Related]
17. Preoperative MRI features predicting very early recurrence of intrahepatic mass-forming cholangiocarcinoma after R0 resection: a comparison with the AJCC 8th edition staging system.
Chen S; Wan L; Zhao R; Peng W; Zou S; Zhang H
Abdom Radiol (NY); 2024 Jan; 49(1):21-33. PubMed ID: 37815613
[TBL] [Abstract][Full Text] [Related]
18. MRI features predict microvascular invasion in intrahepatic cholangiocarcinoma.
Ma X; Liu L; Fang J; Rao S; Lv L; Zeng M; Shi Y; Yang C
Cancer Imaging; 2020 Jun; 20(1):40. PubMed ID: 32576283
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of mass-forming intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma: based on the multivariate analysis of contrast-enhanced computed tomography findings.
Zhao YJ; Chen WX; Wu DS; Zhang WY; Zheng LR
Abdom Radiol (NY); 2016 May; 41(5):978-89. PubMed ID: 27193795
[TBL] [Abstract][Full Text] [Related]
20. Volumetric CT Texture Analysis of Intrahepatic Mass-Forming Cholangiocarcinoma for the Prediction of Postoperative Outcomes: Fully Automatic Tumor Segmentation Versus Semi-Automatic Segmentation.
Park S; Lee JM; Park J; Lee J; Bae JS; Kim JH; Joo I
Korean J Radiol; 2021 Nov; 22(11):1797-1808. PubMed ID: 34402247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
